Spectral Med Stock Number Of Shares Shorted
| EDTXF Stock | USD 0.61 0.02 3.39% |
Fundamental analysis of Spectral Med allows traders to better anticipate movements in Spectral Med's stock price by examining its financial health and performance throughout various phases of its business cycle.
Spectral |
Spectral Med Company Number Of Shares Shorted Analysis
Spectral Med's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Spectral Med has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Spectral Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Spectral Med's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Spectral Med could also be used in its relative valuation, which is a method of valuing Spectral Med by comparing valuation metrics of similar companies.Spectral Med is currently under evaluation in number of shares shorted category among its peers.
Spectral Fundamentals
| Return On Equity | -7.84 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (6.38) % | |||
| Current Valuation | 65.99 M | |||
| Shares Outstanding | 278.22 M | |||
| Shares Owned By Insiders | 20.43 % | |||
| Shares Owned By Institutions | 13.18 % | |||
| Price To Earning | (13.69) X | |||
| Price To Book | 51.73 X | |||
| Price To Sales | 42.75 X | |||
| Revenue | 2.05 M | |||
| Gross Profit | 1.22 M | |||
| EBITDA | (8.46 M) | |||
| Net Income | (8.79 M) | |||
| Cash And Equivalents | 3.47 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 537 K | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 2.38 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (8.7 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 1.24 | |||
| Number Of Employees | 31 | |||
| Beta | 0.99 | |||
| Market Capitalization | 66.02 M | |||
| Total Asset | 11.55 M | |||
| Retained Earnings | (51.99 M) | |||
| Working Capital | 4.36 M | |||
| Current Asset | 6.33 M | |||
| Current Liabilities | 1.96 M | |||
| Z Score | 67.6 | |||
| Net Asset | 11.55 M |
About Spectral Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Spectral Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spectral Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spectral Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Spectral Pink Sheet
Spectral Med financial ratios help investors to determine whether Spectral Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.